Reduktionen i urin CTx niveauet var signifikant korreleret med det primære endepunkt SMPR (Kendall- tau- b, p < 0, 001).
This reduction in urinary CTx levels was significantly correlated with the primary efficacy endpoint SMPR (Kendall-tau-b (p < 0.001)).